Morgan D. McSweeney

602 total citations
17 papers, 459 citations indexed

About

Morgan D. McSweeney is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Morgan D. McSweeney has authored 17 papers receiving a total of 459 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 6 papers in Epidemiology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Morgan D. McSweeney's work include Inhalation and Respiratory Drug Delivery (7 papers), Respiratory viral infections research (6 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Morgan D. McSweeney is often cited by papers focused on Inhalation and Respiratory Drug Delivery (7 papers), Respiratory viral infections research (6 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Morgan D. McSweeney collaborates with scholars based in United States, South Korea and United Kingdom. Morgan D. McSweeney's co-authors include Samuel K. Lai, Raymond J. Pickles, William C. Zamboni, Scott P. Commins, M. Gregory Forest, Yanguang Cao, Timothy Wessler, Lauren Price, Joseph Piscitelli and Delesha M. Carpenter and has published in prestigious journals such as SHILAP Revista de lepidopterología, Advanced Drug Delivery Reviews and Journal of Controlled Release.

In The Last Decade

Morgan D. McSweeney

15 papers receiving 453 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Morgan D. McSweeney United States 12 170 140 98 97 82 17 459
Jasmine Edelstein United States 6 186 1.1× 151 1.1× 52 0.5× 97 1.0× 43 0.5× 8 470
Tian-Lu Cheng Taiwan 8 280 1.6× 238 1.7× 59 0.6× 156 1.6× 48 0.6× 10 602
Péter Bedöcs United States 13 262 1.5× 182 1.3× 99 1.0× 127 1.3× 48 0.6× 22 783
Justin T. Huckaby United States 8 328 1.9× 235 1.7× 151 1.5× 163 1.7× 50 0.6× 14 830
Sean P. Gunsten United States 14 253 1.5× 89 0.6× 223 2.3× 69 0.7× 44 0.5× 21 725
Nanhui Liu China 13 162 1.0× 73 0.5× 54 0.6× 215 2.2× 22 0.3× 21 490
Erik Őrfi Hungary 7 147 0.9× 144 1.0× 57 0.6× 84 0.9× 38 0.5× 9 393
Ryan Hung Canada 9 192 1.1× 80 0.6× 40 0.4× 87 0.9× 29 0.4× 18 488
Milad Shirvaliloo Iran 16 314 1.8× 110 0.8× 42 0.4× 134 1.4× 151 1.8× 43 701
Zongyu Xie China 13 64 0.4× 86 0.6× 94 1.0× 176 1.8× 98 1.2× 33 552

Countries citing papers authored by Morgan D. McSweeney

Since Specialization
Citations

This map shows the geographic impact of Morgan D. McSweeney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Morgan D. McSweeney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Morgan D. McSweeney more than expected).

Fields of papers citing papers by Morgan D. McSweeney

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Morgan D. McSweeney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Morgan D. McSweeney. The network helps show where Morgan D. McSweeney may publish in the future.

Co-authorship network of co-authors of Morgan D. McSweeney

This figure shows the co-authorship network connecting the top 25 collaborators of Morgan D. McSweeney. A scholar is included among the top collaborators of Morgan D. McSweeney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Morgan D. McSweeney. Morgan D. McSweeney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
Zhu, Yong, Alison Schaefer, Morgan D. McSweeney, et al.. (2025). Vaginally-delivered fast-dissolving antibody tablets (FDAT) for on-demand non-hormonal contraception and multi-purpose protection. Journal of Controlled Release. 382. 113662–113662.
3.
Tiruthani, Karthik, Jasper Fuk‐Woo Chan, Alice Ma, et al.. (2024). Engineering a “muco‐trapping” ACE2 ‐immunoglobulin hybrid with picomolar affinity as an inhaled, pan‐variant immunotherapy for COVID ‐19. Bioengineering & Translational Medicine. 9(4). e10650–e10650. 3 indexed citations
4.
McSweeney, Morgan D., Alison Schaefer, Whitney Wolf, et al.. (2024). Inhaled “Muco‐Trapping” Monoclonal Antibody Effectively Treats Established Respiratory Syncytial Virus (RSV) Infections. Advanced Science. 11(12). e2306729–e2306729. 8 indexed citations
5.
McSweeney, Morgan D., Ian E. Stewart, Hyunah Kang, et al.. (2022). Stable nebulization and muco‐trapping properties of regdanvimab/ IN ‐006 support its development as a potent, dose‐saving inhaled therapy for COVID ‐19. Bioengineering & Translational Medicine. 8(1). e10391–e10391. 13 indexed citations
6.
McSweeney, Morgan D., Timothy Wessler, Zibo Li, et al.. (2022). A PBPK model recapitulates early kinetics of anti-PEG antibody-mediated clearance of PEG-liposomes. Journal of Controlled Release. 343. 518–527. 14 indexed citations
7.
8.
McSweeney, Morgan D., et al.. (2021). Anaphylaxis to Pfizer/BioNTech mRNA COVID-19 Vaccine in a Patient With Clinically Confirmed PEG Allergy. SHILAP Revista de lepidopterología. 2. 715844–715844. 50 indexed citations
9.
McSweeney, Morgan D., Tao Zhang, Zibo Li, et al.. (2021). High MW polyethylene glycol prolongs circulation of pegloticase in mice with anti-PEG antibodies. Journal of Controlled Release. 338. 804–812. 13 indexed citations
10.
Tiruthani, Karthik, et al.. (2020). Challenges and opportunities for antiviral monoclonal antibodies as COVID-19 therapy. Advanced Drug Delivery Reviews. 169. 100–117. 57 indexed citations
11.
McSweeney, Morgan D., et al.. (2020). Pre-treatment with high molecular weight free PEG effectively suppresses anti-PEG antibody induction by PEG-liposomes in mice. Journal of Controlled Release. 329. 774–781. 36 indexed citations
12.
Lai, Samuel K., Morgan D. McSweeney, & Raymond J. Pickles. (2020). Learning from past failures: Challenges with monoclonal antibody therapies for COVID-19. Journal of Controlled Release. 329. 87–95. 23 indexed citations
13.
McSweeney, Morgan D., Lauren Price, Timothy Wessler, et al.. (2019). Overcoming anti-PEG antibody mediated accelerated blood clearance of PEGylated liposomes by pre-infusion with high molecular weight free PEG. Journal of Controlled Release. 311-312. 138–146. 70 indexed citations
14.
Parker, Christina L., Morgan D. McSweeney, Andrew T. Lucas, et al.. (2019). Pretargeted delivery of PEG-coated drug carriers to breast tumors using multivalent, bispecific antibody against polyethylene glycol and HER2. Nanomedicine Nanotechnology Biology and Medicine. 21. 102076–102076. 21 indexed citations
15.
McSweeney, Morgan D., Timothy Wessler, Lauren Price, et al.. (2018). A minimal physiologically based pharmacokinetic model that predicts anti-PEG IgG-mediated clearance of PEGylated drugs in human and mouse. Journal of Controlled Release. 284. 171–178. 66 indexed citations
16.
Fix, Samantha M., et al.. (2018). Accelerated Clearance of Ultrasound Contrast Agents Containing Polyethylene Glycol is Associated with the Generation of Anti-Polyethylene Glycol Antibodies. Ultrasound in Medicine & Biology. 44(6). 1266–1280. 46 indexed citations
17.
McSweeney, Morgan D., et al.. (2018). Physician Awareness of Immune Responses to Polyethylene Glycol‐Drug Conjugates. Clinical and Translational Science. 11(2). 162–165. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jasmine Edelstein Breakdown of academic impact, for papers by Tian-Lu Cheng Breakdown of academic impact, for papers by Péter Bedöcs Breakdown of academic impact, for papers by Justin T. Huckaby Breakdown of academic impact, for papers by Sean P. Gunsten Breakdown of academic impact, for papers by Nanhui Liu Breakdown of academic impact, for papers by Erik Őrfi Breakdown of academic impact, for papers by Ryan Hung Breakdown of academic impact, for papers by Milad Shirvaliloo Breakdown of academic impact, for papers by Zongyu Xie
Rankless by CCL
2026